Benedict Cumberbatch gives fans an update regarding the future of a potential Sherlock revival, though it probably isn't what they were hoping to hear ...

Benedict Cumberbatch discusses a potential return to Sherlock, and what it would take for him to reprise his role.

Irene Schwartz Shere died on January 22, 2025, at 78 years of age, after her 5th bout of cancer, as announced by her beloved daughter Holly Taya Shere, her beloved son Brett Shere, beloved ...

The iconic detective Sherlock Holmes was created by Sir Arthur Conan Doyle. First appearing in print in the 1887 story A Study in Scarlet, Holmes has since been reimagined, recreated, and ...

On April 8, Bob Dylan will perform at the Adler Theatre, 136 East 3rd Street, according to promoters. Tickets will go on sale Friday at 10 a.m. and will vary in price from $62.50, $89.50 ...

Both continue to have full plates, but it would be great if they were able to find the time to knock out another batch of Sherlock episodes.

Social network X is trying to capitalize on the uncertainty surrounding ByteDance apps like TikTok and Lemon8 by launching a dedicated vertical video feed. The company is adding a video tab in the ...

Jess started her career at TechRadar, covering news and hardware reviews. Meta, Google, TikTok, and X have each pledged to European lawmakers that they will do more to prevent and remove illegal ...

X has launched a new video tab for US users after TikTok was banned. Industry analysts estimate this strategic move could help X capture a significant portion of TikTok’s 170 million US user ...

X, formerly Twitter, debuted a new feature for its US users on Sunday — a tab dedicated to watching videos on the platform. "The Video Tab has arrived. LFG," X CEO Linda Yaccarino wrote in a ...

BRUSSELS, Jan 20 (Reuters) - Meta's (META.O), opens new tab Facebook, Elon Musk's X, Google's (GOOGL.O), opens new tab YouTube and other tech companies have agreed to do more to tackle online hate ...

On December 23, 2024, XBiotech announced that it was pausing the phase 2 rheumatoid arthritis program for its drug candidate, Natrunix while it seeks to understand the outcome from its recently ...